chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdomen scan, Anaemia, Bacterial test, Biopsy bone, Blood culture
Clinical narrative: Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered.   Follow up attempt is excepted. Further information is requested.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Cardiac monitoring, Cerebellar stroke, Cerebrovascular accident, Computerised tomogram
Clinical narrative: Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered.   Follow up attempt is excepted. Further information is requested.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Culture stool, Culture urine, Electroencephalogram, Fungal test, Haemoglobin decreased
Clinical narrative: Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered.   Follow up attempt is excepted. Further information is requested.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging, Muscle atrophy, Pyrexia, Scan
Clinical narrative: Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered.   Follow up attempt is excepted. Further information is requested.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Serum ferritin increased, Transfusion, White blood cell scan
Clinical narrative: Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered.   Follow up attempt is excepted. Further information is requested.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaemia, Blood test, Brain stem stroke, Cerebellar stroke, Muscle atrophy
Clinical narrative: Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered.   Follow up attempt is excepted. Further information is requested.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Scan, Serum ferritin increased
Clinical narrative: Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered.   Follow up attempt is excepted. Further information is requested.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Cyanosis, Death, Fatigue, Impaired work ability
Clinical narrative: Death
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Lethargy, Somnolence
Clinical narrative: Death
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Fatigue, Feeling cold, Pain in extremity, Skin warm
Clinical narrative: Death
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Death
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Corneal reflex decreased, Facial paralysis
Clinical narrative: Bells Palsy; lost mobility of my face including my eye; This is a spontaneous report from a contactable consumer or other non hcp (patient). A   55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0185), via an unspecified route of administration, administered in left arm on 15Jun2021 08:15  as dose 1, single (Age at vaccination: 55 year old) for covid-19 immunisation. Medical history included eczema, cyst in liver, known allergies for Peniccilin, shell fish, flu shoot, dye for ct scan, nuts, trees, pollen from an unknown date and unknown if ongoing. Concomitant medications included VITAMIN D taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced bells palsy, lost mobility of her face including her eye on 15Jun2021 11:00. It was reported that, Approximately 3hrs after received patients first vaccine she lost mobility of her face including her eye and was diagnosed with Bells Palsy after it was confirmed that she was not having a stroke. Therapeutic measures were taken as a result of events includes Prednisone 60 mg 1 tablet per day, Valacyclovir 3 per day. The outcome for all events was recovering.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased
Clinical narrative: Bells Palsy; lost mobility of my face including my eye; This is a spontaneous report from a contactable consumer or other non hcp (patient). A   55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0185), via an unspecified route of administration, administered in left arm on 15Jun2021 08:15  as dose 1, single (Age at vaccination: 55 year old) for covid-19 immunisation. Medical history included eczema, cyst in liver, known allergies for Peniccilin, shell fish, flu shoot, dye for ct scan, nuts, trees, pollen from an unknown date and unknown if ongoing. Concomitant medications included VITAMIN D taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced bells palsy, lost mobility of her face including her eye on 15Jun2021 11:00. It was reported that, Approximately 3hrs after received patients first vaccine she lost mobility of her face including her eye and was diagnosed with Bells Palsy after it was confirmed that she was not having a stroke. Therapeutic measures were taken as a result of events includes Prednisone 60 mg 1 tablet per day, Valacyclovir 3 per day. The outcome for all events was recovering.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Mobility decreased
Clinical narrative: Bells Palsy; lost mobility of my face including my eye; This is a spontaneous report from a contactable consumer or other non hcp (patient). A   55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0185), via an unspecified route of administration, administered in left arm on 15Jun2021 08:15  as dose 1, single (Age at vaccination: 55 year old) for covid-19 immunisation. Medical history included eczema, cyst in liver, known allergies for Peniccilin, shell fish, flu shoot, dye for ct scan, nuts, trees, pollen from an unknown date and unknown if ongoing. Concomitant medications included VITAMIN D taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced bells palsy, lost mobility of her face including her eye on 15Jun2021 11:00. It was reported that, Approximately 3hrs after received patients first vaccine she lost mobility of her face including her eye and was diagnosed with Bells Palsy after it was confirmed that she was not having a stroke. Therapeutic measures were taken as a result of events includes Prednisone 60 mg 1 tablet per day, Valacyclovir 3 per day. The outcome for all events was recovering.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Experienced odd numbness; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, formulation: solution for injection, Lot Number: Unknown), via an unspecified route of administration, on an unspecified date as first dose, at unknown dose single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. patient received 1st dose of Pfizer Covid 19 vaccine. He experienced odd numbness and that was still lingering/not resolve. The outcome of event was not recovered. Information on the lot/batch number has been requested.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Laboratory test, Lip swelling, Swelling face
Clinical narrative: numb; This is a spontaneous report from a contactable consumer(patient) or other non-health care professional. A 46-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 07Jun2021(Age at vaccination 46) (Batch/Lot Number: EW0196) as dose 1, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. It was reported that morning after the vaccine at night. He got it at 8:30 pm that night and then at 11:30 the next morning at 11am the patient experienced Numb on 08Jun2021, He had been at work a couple of hours and it felt like Novocain for a filling. It went away just after a week it was much better and then four to five days it was very much there. He is concerned about dose number two and he read about Bell's Palsy and he is worried about extreme side effects. It would be nice if someone from Pfizer to get back to him about if people had this type of side effect after the first dose. It is not listed on the four-page thing with the vaccine. Attempted to clarify with caller the date it went away It was like the moustache area, and nose then the bottom and lips. Mostly the moustache area and nose were the focus. Treatment included reported as he saw a doctor. He pushed on it and wasn't totally numb. It was a little bit on the sides by the TMJ joint and the temples had the same weird type of numbness. He was not taken second dose. The patient underwent lab test included herpes test and result was negative. The outcome for the event recovered on 16Jun2021.  Additional Information has been requested. Further information is expected
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes virus test, Hypoaesthesia
Clinical narrative: numb; This is a spontaneous report from a contactable consumer(patient) or other non-health care professional. A 46-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 07Jun2021(Age at vaccination 46) (Batch/Lot Number: EW0196) as dose 1, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. It was reported that morning after the vaccine at night. He got it at 8:30 pm that night and then at 11:30 the next morning at 11am the patient experienced Numb on 08Jun2021, He had been at work a couple of hours and it felt like Novocain for a filling. It went away just after a week it was much better and then four to five days it was very much there. He is concerned about dose number two and he read about Bell's Palsy and he is worried about extreme side effects. It would be nice if someone from Pfizer to get back to him about if people had this type of side effect after the first dose. It is not listed on the four-page thing with the vaccine. Attempted to clarify with caller the date it went away It was like the moustache area, and nose then the bottom and lips. Mostly the moustache area and nose were the focus. Treatment included reported as he saw a doctor. He pushed on it and wasn't totally numb. It was a little bit on the sides by the TMJ joint and the temples had the same weird type of numbness. He was not taken second dose. The patient underwent lab test included herpes test and result was negative. The outcome for the event recovered on 16Jun2021.  Additional Information has been requested. Further information is expected
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Hypotension, Jaundice, Loss of consciousness
Clinical narrative: HPI 51-year-old male from a work site reportedly around 455 complained of shortness of breath, on EMS arrival he had a very thready pulse, which he lost his symptoms they got him into the helicopter, they have been doing CPR for 20 minutes in route here. No medical history is available Medical history unknown surgical history unknown social history unknown family history unknown review of systems unknown
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pulse abnormal, Resuscitation
Clinical narrative: HPI 51-year-old male from a work site reportedly around 455 complained of shortness of breath, on EMS arrival he had a very thready pulse, which he lost his symptoms they got him into the helicopter, they have been doing CPR for 20 minutes in route here. No medical history is available Medical history unknown surgical history unknown social history unknown family history unknown review of systems unknown
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Genital herpes, Oral herpes
Clinical narrative: HERPES OUTBREAK ON GENITAL AREA; HERPES OUTBREAK ON LIP; SHARP PAIN IN THE RIGHT SIDE OF JAW; CONGESTION; This spontaneous report received from a patient concerned an elderly female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and genital herpes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 23-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUN-2021, the subject experienced congestion. On 23-JUN-2021, the subject experienced sharp pain in the right side of jaw. On 25-JUN-2021, the subject experienced herpes outbreak on genital area. On 25-JUN-2021, the subject experienced herpes outbreak on lip. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sharp pain in the right side of jaw on 24-JUN-2021, had not recovered from herpes outbreak on genital area, and herpes outbreak on lip, and the outcome of congestion was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Genital herpes, Oral herpes, Pain in jaw, Sinus congestion
Clinical narrative: HERPES OUTBREAK ON GENITAL AREA; HERPES OUTBREAK ON LIP; SHARP PAIN IN THE RIGHT SIDE OF JAW; CONGESTION; This spontaneous report received from a patient concerned an elderly female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and genital herpes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 23-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUN-2021, the subject experienced congestion. On 23-JUN-2021, the subject experienced sharp pain in the right side of jaw. On 25-JUN-2021, the subject experienced herpes outbreak on genital area. On 25-JUN-2021, the subject experienced herpes outbreak on lip. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sharp pain in the right side of jaw on 24-JUN-2021, had not recovered from herpes outbreak on genital area, and herpes outbreak on lip, and the outcome of congestion was not reported. This report was non-serious.
Age: 60.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Fatigue, Migraine, Myalgia, Nausea
Clinical narrative: OCCASIONAL TINNITUS; VOMITED ENTIRE QUANTITY; NAUSEA; GENERAL MUSCLE ACHING / GENERAL MYALGIA / ENTIRE BODY ACHING; FATIGUE; MIGRAINE; SOME CONFUSION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient experienced severe reaction when treated with rabies vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 25-JUN-2021 15:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 25-JUN-2021, the subject experienced migraine. On 25-JUN-2021, the subject experienced some confusion. On 25-JUN-2021, the subject experienced general muscle aching / general myalgia / entire body aching. On 25-JUN-2021, the subject experienced fatigue. On 26-JUN-2021, the subject experienced occasional tinnitus. On 26-JUN-2021, the subject experienced vomited entire quantity. On 26-JUN-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomited entire quantity, was recovering from fatigue, migraine, nausea, and some confusion, and had not recovered from general muscle aching / general myalgia / entire body aching, and occasional tinnitus. This report was non-serious.
Age: 60.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pain, Sleep disorder, Tinnitus, Vomiting
Clinical narrative: OCCASIONAL TINNITUS; VOMITED ENTIRE QUANTITY; NAUSEA; GENERAL MUSCLE ACHING / GENERAL MYALGIA / ENTIRE BODY ACHING; FATIGUE; MIGRAINE; SOME CONFUSION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient experienced severe reaction when treated with rabies vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 25-JUN-2021 15:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 25-JUN-2021, the subject experienced migraine. On 25-JUN-2021, the subject experienced some confusion. On 25-JUN-2021, the subject experienced general muscle aching / general myalgia / entire body aching. On 25-JUN-2021, the subject experienced fatigue. On 26-JUN-2021, the subject experienced occasional tinnitus. On 26-JUN-2021, the subject experienced vomited entire quantity. On 26-JUN-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomited entire quantity, was recovering from fatigue, migraine, nausea, and some confusion, and had not recovered from general muscle aching / general myalgia / entire body aching, and occasional tinnitus. This report was non-serious.
Age: 60.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Vomiting
Clinical narrative: OCCASIONAL TINNITUS; VOMITED ENTIRE QUANTITY; NAUSEA; GENERAL MUSCLE ACHING / GENERAL MYALGIA / ENTIRE BODY ACHING; FATIGUE; MIGRAINE; SOME CONFUSION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient experienced severe reaction when treated with rabies vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 25-JUN-2021 15:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 25-JUN-2021, the subject experienced migraine. On 25-JUN-2021, the subject experienced some confusion. On 25-JUN-2021, the subject experienced general muscle aching / general myalgia / entire body aching. On 25-JUN-2021, the subject experienced fatigue. On 26-JUN-2021, the subject experienced occasional tinnitus. On 26-JUN-2021, the subject experienced vomited entire quantity. On 26-JUN-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomited entire quantity, was recovering from fatigue, migraine, nausea, and some confusion, and had not recovered from general muscle aching / general myalgia / entire body aching, and occasional tinnitus. This report was non-serious.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Troponin increased
Clinical narrative: Chest pain/myocarditis requiring inpatient admission; elevated troponins but normal cardiac function. Discharged home after 3 days in good condition
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac function test normal, Chest pain, Echocardiogram normal, Myocarditis, Troponin increased
Clinical narrative: Chest pain/myocarditis requiring inpatient admission; elevated troponins but normal cardiac function. Discharged home after 3 days in good condition
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness, Presyncope
Clinical narrative: Ten minutes after being vaccinated I fainted and the pharmacy called an ambulance. The paramedics recommended I go with them in an ambulance to the ER. I agreed and received a chest X-ray and Anti nausea medicine. I
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Syncope
Clinical narrative: Ten minutes after being vaccinated I fainted and the pharmacy called an ambulance. The paramedics recommended I go with them in an ambulance to the ER. I agreed and received a chest X-ray and Anti nausea medicine. I
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, UNK, COVID19
Symptoms: Peripheral swelling, Swelling, Ultrasound scan
Clinical narrative: Caused lymphoma/Enlargements are malignant; A large lump in my left armpit the size of an egg and a small, pea-sized lump in my neck, left sid/enlarged lymph node in my armpit and lymph node in my neck alsoe; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EW0176) via an unspecified route of administration, administered in arm left on 26Apr2021 14:45 (at the age of 70-year-old) at dose 2, single for COVID-19 immunization. The patient medical history was not reported. Patient previously received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EP7355) via an un-specified route of administration, administered in arm left on 29Mar2021 09:15 at dose 1, single for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Con-concomitant medication included vitamins nos (VITAMINS NOS) (received within 2 weeks of vaccination). On 13May2021 07:30 the patient experienced caused lymphoma/enlargements are malignant, a large lump in my left armpit the size of an egg and a small, pea-sized lump in my neck, left side/enlarged lymph node in my armpit and lymph node in my neck also. Reported Event: On the 17th day following second dose, patient noticed a large lump in my left armpit the size of an egg and a small, pea-sized lump in my neck, left side. Patient M.D. ordered ultrasounds of both areas. Doctors and radiologists report stated ultrasound showed prominent enlarged lymph node in my armpit and lymph node in my neck also. They state that it may be due to the Covid vaccine. So far, these enlargements have not resolved. It was recommended that the ultrasounds be repeated in 3 months. Patient terrified that the vaccine may have caused lymphoma. Doctors cannot tell patient yet if these enlargements are malignant. Patient have already spent a lot of money on doctors and ultrasounds and more yet to come. Patient felt you should be made aware. Adverse event led to physician office visit. Patient lab data included ultrasounds of both areas showed prominent enlarged lymph node in my armpit and lymph node in my neck also. Patient received treatment had two ultrasounds. Outcome of the events was not resolved.  Follow-up attempts are needed: Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, UNK, COVID19
Symptoms: Investigation, Lymphadenopathy, Lymphoma
Clinical narrative: Caused lymphoma/Enlargements are malignant; A large lump in my left armpit the size of an egg and a small, pea-sized lump in my neck, left sid/enlarged lymph node in my armpit and lymph node in my neck alsoe; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EW0176) via an unspecified route of administration, administered in arm left on 26Apr2021 14:45 (at the age of 70-year-old) at dose 2, single for COVID-19 immunization. The patient medical history was not reported. Patient previously received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EP7355) via an un-specified route of administration, administered in arm left on 29Mar2021 09:15 at dose 1, single for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Con-concomitant medication included vitamins nos (VITAMINS NOS) (received within 2 weeks of vaccination). On 13May2021 07:30 the patient experienced caused lymphoma/enlargements are malignant, a large lump in my left armpit the size of an egg and a small, pea-sized lump in my neck, left side/enlarged lymph node in my armpit and lymph node in my neck also. Reported Event: On the 17th day following second dose, patient noticed a large lump in my left armpit the size of an egg and a small, pea-sized lump in my neck, left side. Patient M.D. ordered ultrasounds of both areas. Doctors and radiologists report stated ultrasound showed prominent enlarged lymph node in my armpit and lymph node in my neck also. They state that it may be due to the Covid vaccine. So far, these enlargements have not resolved. It was recommended that the ultrasounds be repeated in 3 months. Patient terrified that the vaccine may have caused lymphoma. Doctors cannot tell patient yet if these enlargements are malignant. Patient have already spent a lot of money on doctors and ultrasounds and more yet to come. Patient felt you should be made aware. Adverse event led to physician office visit. Patient lab data included ultrasounds of both areas showed prominent enlarged lymph node in my armpit and lymph node in my neck also. Patient received treatment had two ultrasounds. Outcome of the events was not resolved.  Follow-up attempts are needed: Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Rash, Sleep disorder
Clinical narrative: intense itching rash cough sob seen in ED
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Dyspnoea, Pruritus, Rash
Clinical narrative: intense itching rash cough sob seen in ED
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Influenza like illness, Pyrexia, Urticaria
Clinical narrative: hives all over body an hour after receiving the vaccine, terrible headache, dizzy, low grade fever and severe flu like symtoms, Took benadryl for two days along with tylenol. called employee health at  where i work in the lab
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Exposure during pregnancy, Myalgia, Rash
Clinical narrative: Currently pregnant due date 7/27/21. Developed a rash w muscle and joint pain on right arm in May 2021, several months after vaccine was administered. Symptoms improved but have recently flared up again.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness unilateral, Tinnitus, Vertigo
Clinical narrative: Loss of hearing on left ear completely to the point of vertigo symptoms; only 80 percent of hearing has returned despite going to doctor and using ear drops; development of Tinnitus since 80 percent of hearing returned.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Cheilitis, Lip swelling
Clinical narrative: Lips become puffy/inflamed. Visited ER based on phone nurse recommendation to get evaluated.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain
Clinical narrative: Light to moderate chest discomfort/pain.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Feeling hot, Hyperhidrosis, Injection site erythema, Injection site pruritus
Clinical narrative: Within approximately 2 minutes of getting the shot I started to feel clammy and warm. Then started to sweat heavily. This lasted for about 5 minutes. 7 days after my shot I developed a red itchy bump at the injection site.